Fresenius Medical Care AG
FMS
$23.98
$0.421.78%
| Weiss Ratings | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C+ | |||
| Rating Factors | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Excellent | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.54 | |||
| Price History | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.78% | |||
| 30-Day Total Return | -1.03% | |||
| 60-Day Total Return | -0.33% | |||
| 90-Day Total Return | 12.21% | |||
| Year to Date Total Return | 8.26% | |||
| 1-Year Total Return | 18.47% | |||
| 2-Year Total Return | 30.84% | |||
| 3-Year Total Return | -12.53% | |||
| 5-Year Total Return | -30.08% | |||
| 52-Week High % Change | -6.69% | |||
| 52-Week Low % Change | 31.40% | |||
| Price | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $25.25 | |||
| 52-Week Low Price | $17.93 | |||
| 52-Week Low Price (Date) | Aug 08, 2024 | |||
| 52-Week High Price (Date) | Jan 31, 2025 | |||
| Valuation | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 13.91B | |||
| Enterprise Value | 25.60B | |||
| Price/Earnings (TTM) | 11.90 | |||
| Earnings Per Share (TTM) | 1.98 | |||
| Earnings Per Share Growth | 7.95% | |||
| Price/Earnings To Growth | 1.50 | |||
| Price/Sales (TTM) | 0.33 | |||
| Price/Book (Q) | 0.46 | |||
| Enterprise Value/Revenue (TTM) | 1.22 | |||
| Price | $23.98 | |||
| Enterprise Value/EBITDA (TTM) | 8.25 | |||
| Enterprise Value/EBIT | 15.38 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 293.41M | |||
| Dividend Yield | 1.88% | |||
| Div. Per Share (Most Recent) | $0.44 | |||
| Dividend Per Share (TTM) | $0.44 | |||
| Payout Ratio (TTM) | 64.37% | |||
| Dividend Per Share (Most Recent) | $0.44 | |||
| Company Info | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 49 6172 609 0 | |||
| Address | -- | |||
| Website | www.freseniusmedicalcare.com | |||
| Country | Germany | |||
| Year Founded | 1996 | |||
| Profitability | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.96% | |||
| Profit Margin | 2.79% | |||
| Management Effectiveness | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.88% | |||
| Return on Equity | 4.91% | |||
| Income Statement | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 20.91B | |||
| Total Revenue (TTM) | 20.91B | |||
| Revenue Per Share | $71.27 | |||
| Gross Profit (TTM) | 5.14B | |||
| EBITDA (TTM) | 3.10B | |||
| EBIT (TTM) | 1.67B | |||
| Net Income (TTM) | 583.85M | |||
| Net Income Avl. to Common (TTM) | 583.85M | |||
| Total Revenue Growth (Q YOY) | 0.94% | |||
| Earnings Growth (Q YOY) | -54.42% | |||
| EPS Diluted (TTM) | 1.98 | |||
| EPS Diluted Growth (Q YOY) | -65.97% | |||
| Balance Sheet | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.39B | |||
| Cash Per Share (Q) | $4.74 | |||
| Total Current Assets (Q) | 8.20B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 16.33B | |||
| Current Ratio (Q) | 1.400 | |||
| Book Value Per Share (Q) | $51.43 | |||
| Total Assets (Q) | 34.75B | |||
| Total Current Liabilities (Q) | 5.86B | |||
| Total Debt (Q) | 11.39B | |||
| Total Liabilities (Q) | 18.43B | |||
| Total Common Equity (Q) | 15.09B | |||
| Cash Flow | FMS - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -95.89M | |||
| Cash from Financing (TTM) | -2.77B | |||
| Net Change in Cash (TTM) | -254.10M | |||
| Levered Free Cash Flow (TTM) | 2.20B | |||
| Cash from Operations (TTM) | 2.58B | |||
